Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials-Reference-Cited by-同舟云学术

Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials

Published:2018-09 Issue:9 Volume:6 Page:691-704
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Perkovic Vlado,de Zeeuw Dick,Mahaffey Kenneth W,Fulcher Greg,Erondu Ngozi,Shaw Wayne,Barrett Terrance D,Weidner-Wells Michele,Deng Hsiaowei,Matthews David R,Neal Bruce

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference36 articles.

1. Worldwide access to treatment for end-stage kidney disease: a systematic review;Liyanage;Lancet,2015

2. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study;Stratton;BMJ,2000

3. Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials;Zoungas;Lancet Diabetes Endocrinol,2017

4. Intensive glucose control improves kidney outcomes in patients with type 2 diabetes;Perkovic;Kidney Int,2013

5. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease;Kidney Int Suppl,2013

Cited by 503 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gliflozins in the Treatment of Non-diabetic Experimental Cardiovascular Diseases;Physiological Research;2024-08-31

2. Recent and Upcoming Therapies for Management of Type 2 Diabetes: A Review;Preventive Medicine: Research & Reviews;2024-08-13

3. Retrospective analysis of the effect of SGLT-2 inhibitors on renal function in patients with type 2 diabetes in the real world;Frontiers in Pharmacology;2024-08-05

4. Mendelian randomization study of sodium–glucose cotransporter 2 inhibitors in cardiac and renal diseases;Journal of International Medical Research;2024-08

5. Canagliflozin attenuates post-resuscitation myocardial dysfunction in diabetic rats by inhibiting autophagy through the PI3K/Akt/mTOR pathway;iScience;2024-08